[Peripheral neurosarcoidosis and chronic C hepatitis: Responsibility of antiviral therapies].
M
M
Assenova
A
A
Sacko
J-F
JF
Cadranel
M
M
Logak
D000998:Antiviral Agents / Q000009:adverse effects*; D002493:Central Nervous System Diseases / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis; D056486:Chemical and Drug Induced Liver Injury / Q000150:complications* / Q000175:diagnosis; D005260:Female; D020275:Guillain-Barre Syndrome / Q000139:chemically induced / Q000150:complications / Q000175:diagnosis; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000175:diagnosis / Q000209:etiology; D006801:Humans; D008875:Middle Aged; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis; D012507:Sarcoidosis / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis
D000998:Antiviral Agents